CY1117848T1 - Παραγωγα πολυμυξινης και χρησεις αυτων - Google Patents

Παραγωγα πολυμυξινης και χρησεις αυτων

Info

Publication number
CY1117848T1
CY1117848T1 CY20161100502T CY161100502T CY1117848T1 CY 1117848 T1 CY1117848 T1 CY 1117848T1 CY 20161100502 T CY20161100502 T CY 20161100502T CY 161100502 T CY161100502 T CY 161100502T CY 1117848 T1 CY1117848 T1 CY 1117848T1
Authority
CY
Cyprus
Prior art keywords
relates
present
polymyxin
derivative
gram
Prior art date
Application number
CY20161100502T
Other languages
Greek (el)
English (en)
Inventor
Martti Vaara
Timo Vaara
Original Assignee
Northern Antibiotics Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northern Antibiotics Oy filed Critical Northern Antibiotics Oy
Publication of CY1117848T1 publication Critical patent/CY1117848T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62—Polymyxins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CY20161100502T 2006-08-11 2016-06-09 Παραγωγα πολυμυξινης και χρησεις αυτων CY1117848T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83742606P 2006-08-11 2006-08-11
DKPA200601055 2006-08-11
PCT/FI2007/050441 WO2008017734A1 (en) 2006-08-11 2007-08-10 Polymyxin derivatives and uses thereof

Publications (1)

Publication Number Publication Date
CY1117848T1 true CY1117848T1 (el) 2017-05-17

Family

ID=39032653

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100502T CY1117848T1 (el) 2006-08-11 2016-06-09 Παραγωγα πολυμυξινης και χρησεις αυτων

Country Status (21)

Country Link
EP (2) EP2057185B1 (cg-RX-API-DMAC7.html)
JP (1) JP5226685B2 (cg-RX-API-DMAC7.html)
KR (2) KR101502453B1 (cg-RX-API-DMAC7.html)
CN (2) CN103059106B (cg-RX-API-DMAC7.html)
AU (1) AU2007283514B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0715095B8 (cg-RX-API-DMAC7.html)
CA (1) CA2694289C (cg-RX-API-DMAC7.html)
CY (1) CY1117848T1 (cg-RX-API-DMAC7.html)
DK (1) DK2057185T3 (cg-RX-API-DMAC7.html)
ES (1) ES2575521T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20160552T1 (cg-RX-API-DMAC7.html)
HU (1) HUE028271T2 (cg-RX-API-DMAC7.html)
IL (2) IL196693B (cg-RX-API-DMAC7.html)
MX (1) MX2009001398A (cg-RX-API-DMAC7.html)
NO (1) NO341982B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ575421A (cg-RX-API-DMAC7.html)
PL (1) PL2057185T3 (cg-RX-API-DMAC7.html)
PT (1) PT2057185E (cg-RX-API-DMAC7.html)
RU (1) RU2455311C2 (cg-RX-API-DMAC7.html)
SI (1) SI2057185T1 (cg-RX-API-DMAC7.html)
WO (1) WO2008017734A1 (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
FI20085469A0 (fi) * 2008-02-08 2008-05-16 Northern Antibiotics Oy Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä
US8343912B2 (en) 2008-12-23 2013-01-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
WO2012051663A1 (en) * 2010-10-21 2012-04-26 Monash University Antimicrobial compounds
BR112014012016A2 (pt) * 2011-11-18 2017-05-16 Cantab Anti-Infectives Ltd compostos
PL2999711T3 (pl) * 2013-05-22 2022-09-26 Spero Therapeutics, Inc. Pochodne polimyksyny i ich zastosowanie w terapii skojarzonej razem z różnymi antybiotykami
DK3116897T3 (da) * 2014-03-11 2022-03-28 Spero Therapeutics Inc Polymyxinderivater og deres anvendelse i kombinationsterapi sammen med forskellige antibiotika
KR101664106B1 (ko) 2014-09-11 2016-10-10 한국화학연구원 폴리믹신 b 화합물을 포함하는 심혈관 질환의 예방 및 치료용 약학적 조성물
CN107108699A (zh) * 2014-11-26 2017-08-29 新药物许可控股有限公司 化合物
CA2970546A1 (en) 2014-12-16 2016-06-23 Micurx Pharmaceuticals, Inc. Antimicrobial polymyxins for treatment of bacterial infections
WO2016097754A1 (en) * 2014-12-18 2016-06-23 Helperby Therapeutics Limited Novel combination and use
FI126143B (en) * 2015-01-15 2016-07-15 Northern Antibiotics Oy Polymyxine derivative and its uses
US9763996B2 (en) 2015-01-16 2017-09-19 Northern Antibiotics, Ltd. Polymyxin derivative and uses thereof
CN104672307B (zh) * 2015-03-23 2017-09-29 吉林大学 一种提高阳离子短肽抗菌性和稳定性的方法
EP3072956A1 (en) * 2015-03-25 2016-09-28 Université de Fribourg Selective culture medium for polymyxin-resistant, gram-negative bacteria
FR3036406B1 (fr) 2015-05-20 2019-07-19 Biomerieux Identification des bacteries resistantes aux carbapenemes par impermeabilite membranaire
WO2017083859A1 (en) * 2015-11-12 2017-05-18 The Trustees Of Columbia University In The City Of New York Rational drug design targeting resistant gram-negative bacterial infections to polymyxin-class antibiotics
WO2017189868A1 (en) * 2016-04-27 2017-11-02 Spero Opco Serine replacement polymyxin analogues useful as antibiotic potentiators
WO2017189866A1 (en) * 2016-04-27 2017-11-02 Spero Opco Polymyxin analogs useful as antibiotic potentiators
GB201703898D0 (en) 2017-03-10 2017-04-26 Helperby Therapeautics Ltd Method
GB201704620D0 (en) 2017-03-23 2017-05-10 Helperby Therapeautics Ltd Combinations
CN111527100A (zh) * 2017-11-02 2020-08-11 昆士兰大学 肽类抗生素
EP3560489A1 (en) * 2018-04-27 2019-10-30 European Molecular Biology Laboratory Pharmaceutical compositions for prevention and/or treatment of infections and antibacterial-induced dysfunctions
BR112020026663A2 (pt) 2018-06-25 2021-03-23 Spero Therapeutics, Inc. Compostos
WO2020018173A1 (en) * 2018-07-19 2020-01-23 Northeastern University Compounds with antimicrobial properties
CN110179967A (zh) * 2019-05-28 2019-08-30 中国医药集团总公司四川抗菌素工业研究所 多粘菌素母核和一种抗生素的组合物及其应用
IT201900025414A1 (it) * 2019-12-23 2021-06-23 Univ Bologna Alma Mater Studiorum Composto per il trattamento della sindrome emolitico uremica
WO2021150792A1 (en) 2020-01-21 2021-07-29 Micurx Pharmaceuticals, Inc. Novel compounds and composition for targeted therapy of kidney-associated cancers
CN118028504B (zh) * 2022-08-30 2024-08-02 四川大学华西医院 一类phoQ基因突变体、应用及其验证方法
WO2024123712A1 (en) * 2022-12-04 2024-06-13 Genentech, Inc. Analysis of candidate cytotoxic compositions
CN120399010B (zh) * 2025-07-01 2025-09-12 杭州肽佳生物科技有限公司 抗生素多粘菌素的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450687A (en) 1966-02-24 1969-06-17 Pfizer & Co C Lower alkanoyl esters of polymyxin antibiotics
JPS4915537B1 (cg-RX-API-DMAC7.html) 1970-03-25 1974-04-16
BE754411A (fr) 1969-08-05 1971-02-04 Rhone Poulenc Sa Cyclopeptides derives des polymyxines et leur
GB2128617A (en) 1982-10-06 1984-05-02 Martti Vaara Polypeptides for use in antibacterial therapy
US20040063754A1 (en) * 2000-11-20 2004-04-01 Hisashi Takahashi Dehalogeno compounds
CA2444637A1 (en) 2001-01-16 2002-07-18 Ramot University Authority For Applied Research & Industrial Development Ltd. Hybrid peptides for treatment of bacteremia and septicemia
EP1340506B1 (en) * 2002-03-01 2006-12-27 CHIESI FARMACEUTICI S.p.A. Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion

Also Published As

Publication number Publication date
JP5226685B2 (ja) 2013-07-03
HRP20160552T1 (hr) 2016-07-15
PT2057185E (pt) 2016-06-17
BRPI0715095A2 (pt) 2013-10-15
NO341982B1 (no) 2018-03-05
HUE028271T2 (en) 2016-12-28
NZ575421A (en) 2011-11-25
CA2694289A1 (en) 2008-02-14
RU2455311C2 (ru) 2012-07-10
CA2694289C (en) 2015-04-07
EP3078672A1 (en) 2016-10-12
CN101501063B (zh) 2014-03-12
KR101502453B1 (ko) 2015-03-24
WO2008017734A8 (en) 2009-07-30
EP2057185B1 (en) 2016-05-11
IL220270A0 (en) 2012-07-31
NO20090674L (no) 2009-05-08
MX2009001398A (es) 2009-02-17
BRPI0715095B1 (pt) 2018-08-07
JP2010500331A (ja) 2010-01-07
CN103059106A (zh) 2013-04-24
SI2057185T1 (sl) 2016-10-28
PL2057185T3 (pl) 2016-09-30
EP2057185A1 (en) 2009-05-13
IL196693B (en) 2018-01-31
CN101501063A (zh) 2009-08-05
IL196693A0 (en) 2009-11-18
AU2007283514B2 (en) 2012-09-06
KR20090045932A (ko) 2009-05-08
WO2008017734A1 (en) 2008-02-14
KR20150008198A (ko) 2015-01-21
DK2057185T3 (en) 2016-06-13
BRPI0715095B8 (pt) 2021-05-25
EP2057185A4 (en) 2009-08-19
ES2575521T3 (es) 2016-06-29
RU2009107857A (ru) 2010-09-20
CN103059106B (zh) 2015-01-14
AU2007283514A1 (en) 2008-02-14

Similar Documents

Publication Publication Date Title
CY1117848T1 (el) Παραγωγα πολυμυξινης και χρησεις αυτων
CY1118625T1 (el) Παραγωγα πολυμυξινης με βραχεια ουρα λιπαρου οξεος και χρησεις αυτων
CY1109970T1 (el) Παραγωγα 6-11 δικυκλικου κετολιδιου
CY1124117T1 (el) Ετεροκυκλικες αλκυνυλοβενζολικες ενωσεις και ιατρικες συνθεσεις και χρησεις αυτων
CY1119376T1 (el) Αντισωματα ειδικα για τη μορφη πρωτοϊνιδιου της βητα-αμυλοειδους πρωτεϊνης
CY1119075T1 (el) Αναστολεις κινασης mtor για ενδειξεις ογκολογιας και παθησεις που συσχετιζονται με την ατραπο mtor/p13k/akt
CY1120512T1 (el) Βιοσυζευγματα κατασκευασμενα απο ανασυνδυασμενες ν-γλυκοζυλιωμενες πρωτεϊνες απο προκαρυωτικα κυτταρα
EA202090495A1 (ru) Производные 6-амино-7,9-дигидро-8h-пурин-8-она в качестве иммуностимулирующих агонистов toll-подобного рецептора 7 (tlr7)
CY1118347T1 (el) Συνθετικα ανοσοενισχυτικα γλυκοπυρανοζυλο-λιπιδιων και συνθεσεις εμβολιων που τα περιεχουν
DOP2011000102A (es) Compuestos heteroaromaticos espirociclicos fusionados para el tratamiento de infecciones bacterianas
CY1112708T1 (el) [1η-ινδολο-5-υλο)-ετεροαρυλοξυ]-(1-αζα-δικυκλο[3.3.1]εννεανια ως χολινεργικοι συνδετες του ν-achr για την θεραπεια των ψυχωτικων και νευροεκφυλιστικων διαταραχων
EA201990551A1 (ru) Антибиотические соединения
MX2009010059A (es) Derivados de quinolina para el tratamiento de enfermedades inflamatorias.
PE20120330A1 (es) Derivados amino-propionicos sustituidos como inhibidores de neprilisina
BR112012018954A2 (pt) derivados de hetaril-[1,8]naftiridina
BR112022001067A2 (pt) Inibidores duplos de atm e dna-pk para uso em terapia antitumoral
CY1111631T1 (el) Παραγωγα των 7-αλκυνυλο-1,8- ναφθυριδονων, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη
ZA200710362B (en) Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use
TW200630374A (en) Thiazolyldihydroindazoles
BR112019007927A2 (pt) conjugados de polimixina ? oligômeros de alginato
CY1114883T1 (el) Καινοφανεις αντιβακτηριακοι παραγοντες για την αγωγη των κατα gram θετικων λοιμωξεων
NZ601262A (en) Nucleic acid complexes
ES2186550B2 (es) Nuevos derivados de oxazolidinonas como antibacterianos.
EA201170121A1 (ru) Лечение инфекций, вызванных антибиотикоустойчивыми бактериями
BRPI1006626B8 (pt) uso de um antibiotico fluoroquinolona para a produção de um medicamento para tratar uma infecção bacteriana pulmonar